Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model.

Vaccines (Basel) · 2021 · PMC8779802 · PMID 35062708

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

At day 14 after challenge, the anti-PRN level significantly increased in group 6 ( p < 0.01) and showed an increasing trend in other groups and peaked at day 21 (group 1–4) and day 28 (group 5).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.